Medications

Repurposed drug shows promise for treating cardiac arrhythmias

Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.

Vaccination

Vaccine printer could help vaccines reach more people

Getting vaccines to people who need them isn't always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don't have the necessary infrastructure.

Immunology

Tracking the pathway to immunity, one cell at a time

Vaccines work their magic by effectively creating immune cells that are long lived, often for over decades. These immune cells create both a protective barrier that can prevent or minimize re-infection and a memory that allows ...

page 2 from 15